44 results on '"Iyo A"'
Search Results
2. Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects
3. Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress
4. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
5. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
6. Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population
7. Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population
8. Fluvoxamine improved cognitive impairments in a patient with schizophrenia
9. PROKR2 is associated with methamphetamine dependence in the Japanese population
10. d-serine enhances extinction of auditory cued fear conditioning via ERK1/2 phosphorylation in mice
11. Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population
12. Impaired P50 suppression in fear extinction in obsessive–compulsive disorder
13. Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression
14. Enhancement of acoustic prepulse inhibition by contextual fear conditioning in mice is maintained even after contextual fear extinction
15. Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population
16. A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis
17. G72 gene is associated with susceptibility to methamphetamine psychosis
18. Evaluating the cognitive decline in early-stage frontotemporal dementia
19. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis
20. Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine
21. Does hypofrontality expand to global brain area in progression of schizophrenia?: A cross-sectional study between first-episode and chronic schizophrenia
22. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: Role of sigma-1 receptors and IP3 receptors
23. Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia
24. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
25. Deficits in auditory P50 inhibition in obsessive–compulsive disorder
26. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder
27. Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia
28. Combined intoxication with methylone and 5-MeO-MIPT
29. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism
30. Increased serum levels of glutamate in adult patients with autism
31. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine
32. No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery
33. Association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and novelty seeking personality in healthy females
34. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy
35. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
36. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder
37. Increased midkine levels in sera from patients with Alzheimerʼs disease
38. Role of brain-derived neurotrophic factor in eating disorders: Recent findings and its pathophysiological implications
39. No changes in serum ghrelin levels in female patients with bulimia nervosa
40. Decreased cell proliferation in the dentate gyrus of α7 nicotinic acetylcholine receptor heterozygous mice
41. Possible role of d-serine in the pathophysiology of Alzheimerʼs disease
42. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: Role of sigma-1 receptors and IP3 receptors
43. Corrigendum to “Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism” [Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (2006) 1529–1531]
44. Corrigendum to “Increased serum levels of glutamate in adult patients with autism” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 1472--1477]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.